Inhibitory effect of resveratrol on swimming motility and adhesion ability against Salmonella enterica serovar Typhimurium infection
Microbial Pathogenesis · 2023-11 · 184 · 106323
DOI: 10.1016/j.micpath.2023.106323 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Pathogenesis, 2023-11. Verfasst von Fei Lou und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Henan University of Animal Husbandry and Economy, Zhengzhou, 450046, China. Hauptthemen laut MEDLINE: Swimming, Salmonella Infections, Animal. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Veterinary Medicine, Henan University of Animal Husbandry and Economy, Zhengzhou, 450046, China.
- Shandong Jinzhuji Pharmaceuticals Co. Ltd., Jinan, 271100, Shandong, China.
- College of Veterinary Medicine, Henan University of Animal Husbandry and Economy, Zhengzhou, 450046, China. Electronic address: finetang@126.com.
Zitieren
APA
Lou, F., Wang, K., Hou, Y., Shang, X., & Tang, F. (2023). Inhibitory effect of resveratrol on swimming motility and adhesion ability against Salmonella enterica serovar Typhimurium infection. Microbial Pathogenesis, 184, 106323. https://doi.org/10.1016/j.micpath.2023.106323
Vancouver
Lou F, Wang K, Hou Y, Shang X, Tang F. Inhibitory effect of resveratrol on swimming motility and adhesion ability against Salmonella enterica serovar Typhimurium infection. Microbial Pathogenesis. 2023;184:106323. doi:10.1016/j.micpath.2023.106323
BibTeX
@article{Lou2023,
author = {Lou, Fei and Wang, Kunli and Hou, Yunfeng and Shang, Xiaolei and Tang, Fayin},
title = {Inhibitory effect of resveratrol on swimming motility and adhesion ability against Salmonella enterica serovar Typhimurium infection},
journal = {Microbial Pathogenesis},
year = {2023},
volume = {184},
pages = {106323},
doi = {10.1016/j.micpath.2023.106323}
}
EUVIMED